Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (31)

2021

  1. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

2013

  1. Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: A case report

    Transplant Infectious Disease, Vol. 15, Núm. 3

2011

  1. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to gram-negative bacilli: A prospective observational study

    Clinical Infectious Diseases, Vol. 53, Núm. 9

2010

  1. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study-authors' response

    Journal of Antimicrobial Chemotherapy

2009

  1. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 416-423

2007

  1. Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients

    Journal of Viral Hepatitis, Vol. 14, Núm. 4, pp. 228-238

2006

  1. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: Results of an open, non-comparative study

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 6, pp. 1172-1180

  2. Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade

    Haemophilia, Vol. 12, Núm. 3, pp. 228-236

2005

  1. Determinación de concentraciones plasmáticas de efavirenz y nevirapina en pacientes hemofílicos con infection por el VIH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 6, pp. 349-352

  2. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis

    Clinical Microbiology and Infection, Vol. 11, Núm. 12, pp. 999-1004

  3. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 7, pp. 3028-3030

2004

  1. Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 11, pp. 4256-4262

2003

  1. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 3, pp. 514-517

  2. Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 1032-1034

  3. Osteomielitis vertebral por Candida spp.

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 21, Núm. 10, pp. 568-570

  4. Recomendaciones para el tratamiento de la infección fúngica invasiva. Infeccion fúngica invasiva por Candida spp.

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 21, Núm. 9, pp. 498-508

  5. Recomendaciones para el tratamiento de la infección por Aspergillus spp.

    Enfermedades Infecciosas y Microbiologia Clinica

2001

  1. Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders

    Hepatology, Vol. 34, Núm. 5, pp. 1035-1040

  2. Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 28, Núm. 5, pp. 450-453

  3. Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3238-3241